Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Risk tolerance in crypto investing guides how much volatility and drawdown you can endure while pursuing growth.
26,560 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Trump says the conflict is complete, but Wall Street expects the Fed to stay hawkish. Oil spikes, inflation worries, ...
A clear, practical guide to reading a 2026 earnings transcript. Learn which numbers matter, how management commentary...
AMZY, the YieldMax AMZN Option Income Strategy ETF, uses a synthetic covered-call approach to generate monthly distri...
A high-profile romance hits the spotlight on Instagram, turning gossip into a live case study in money, brand power, ...
When extreme fan dedication meets stage life, money decisions follow. Learn actionable budgeting, insurance, and reve...
Debt trends are shifting from policy tool to market risk. This report explains how the U.S. rose to financial promine...
Energy markets pivot as renewables rise and fossil fuels adapt; several penny stocks are drawing attention for their ...
A growing cohort of retirees is buying into the Taiwan-centric ETF EWT to capture gains from Taiwan’s chipmakers. The...
April brought a surprising surge for Tower Semiconductor, defying the notion that only the biggest chipmakers can mov...
MGK's gains have been propelled by a tight core of five megacaps, a dynamic that boosts returns but also raises risk ...
A growing slice of wealthier investors is rejecting Treasuries in favor of tax-free muni ETFs that offer higher after...